Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347955 · ClinicalTrials.gov registry record · NA
Double-blind Placebo Surgery Trial for Treatment of Parkinson's Disease
A NA study, sponsored by University of Denver.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03347955 is a NA study that has completed, run by University of Denver. The registered enrollment target is 40 participants.
The verdict
NCT03347955, a NA study, has completed, sponsored by University of Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
A double-blind sham surgery-controlled trial was developed to determine the effectiveness of implantation of human embryonic dopamine neurons into the putamen of patients with advanced Parkinson's disease (PD), with half the patients receiving the implant (n = 20) and half receiving sham surgery (n = 20). The blind was maintained for 12 months before participants were told which surgery they received, at which time those receiving sham surgery could request the implant surgery.
Interventions
- PROCEDURE Sham surgery
- PROCEDURE Neural implantation group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1994-11 |
| Est. Completion | 1999-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347955
The ClinicalTrials.gov registry entry for NCT03347955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Denver, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham surgery is the first listed.
NCT03347955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03347955 about?
NCT03347955 is a clinical study titled "Double-blind Placebo Surgery Trial for Treatment of Parkinson's Disease". A double-blind sham surgery-controlled trial was developed to determine the effectiveness of implantation of human embryonic dopamine neurons into the putamen of patients with advanced Parkinson's disease (PD), with half the patients receiving the implant (n = 20) and half receiving sham surgery (n ...
What is the current status of trial NCT03347955?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 1994-11. Estimated completion is 1999-02.
What interventions are being tested in trial NCT03347955?
The interventions under investigation include: Sham surgery (PROCEDURE), Neural implantation group (PROCEDURE).
Who is sponsoring clinical trial NCT03347955?
This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.